Mgr. Zbyněk Bortlíček

2016

• Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis.

  BUCHLER Tomas BORTLÍČEK Zbyněk POPRACH Alexandr PAVLÍK Tomáš VESKRNOVA Veronika HONZIRKOVA Michaela ZEMANOVA Milada FIALA Ondrej KUBÁČKOVÁ Kateřina SLABÝ Ondřej SVOBODA Marek VYZULA Rostislav DUŠEK Ladislav MELICHAR Bohuslav

  Article in Periodical

  European Urology, year: 2016, volume: 70, edition: 3, DOI

• Panitumumab v 1. linii léčby metastatického kolorektálního karcinomu – výsledky v běžné praxi lepší než v registrační studii

  TOMÁŠEK Jiří MOKRÁ Lenka BORTLÍČEK Zbyněk

  Article in Periodical

  Farmakoterapie, year: 2016, volume: 12, edition: 2

• Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)

  SKŘIČKOVÁ Jana BORTLÍČEK Zbyněk HEJDUK Karel PESEK Milos KOLEK Vitezslav TOMÍŠKOVÁ Marcela GRYGARKOVA Ivona KOUBKOVA Leona CERNOVSKA Marketa ROUBEC Jaromir SALAJKA Frantisek ZEMANOVA Milada COUPKOVA Helena SATANKOVA Monika MAREL Miloslav

  Conference abstract

  Year: 2016, type: Conference abstract

• Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene

  FIALA Ondrej PESEK Milos FINEK Jindrich SVATON Martin MINARIK Marek BENESOVA Lucie BORTLÍČEK Zbyněk KUCERA Radek TOPOLCAN Ondrej

  Article in Periodical

  Anticancer Research, year: 2016, volume: 36, edition: 1

• Pokračovací udržovací léčba pemetrexedemu u nemocných s nemalobuněčným karcinomem plic v České republice

  SKŘIČKOVÁ Jana FRÖHLICH Kateřina KUHN Matyáš BORTLÍČEK Zbyněk HEJDUK Karel PEŠEK Miloš KOLEK Vítězslav GRYGÁRKOVÁ Yvona KOUBKOVÁ Leona ČERNOVSKÁ Markéta TOMÍŠKOVÁ Marcela ROUBEC Jaromír HAVEL Libor SALAJKA František ZEMANOVÁ Milada ČOUPKOVÁ Helena SIXTOVÁ Dimka ŠATÁNKOVÁ Monika MAREL Miloslav

  Article in Periodical

  Onkologie, year: 2016, volume: 10, edition: 1

• Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy

  FIALA Ondrej PESEK Milos FINEK Jindrich SVATON Martin SOREJS Ondrej BORTLÍČEK Zbyněk KUCERA Radek TOPOLCAN Ondrej

  Article in Periodical

  Anticancer Research, year: 2016, volume: 36, edition: 1

• Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib

  FIALA O. PESEK M. FINEK J. RACEK J. MINARIK M. BENESOVA L. BORTLÍČEK Zbyněk SOREJS O. KUCERA R. TOPOLCAN O.

  Article in Periodical

  Neoplasma, year: 2016, volume: 63, edition: 3, DOI

• The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy

  SVATON Martin FIALA Ondrej PESEK Milos BORTLÍČEK Zbyněk MINARIK Marek BENESOVA Lucie TOPOLCAN Ondrej

  Article in Periodical

  Anticancer Research, year: 2016, volume: 36, edition: 3

• Udržovací pokračovací léčba pemetrexed (alimtou) v ČR

  SKŘIČKOVÁ Jana BORTLÍČEK Zbyněk HEJDUK Karel DUŠEK Ladislav TOMÍŠKOVÁ Marcela ŠATÁNKOVÁ Monika BENEJOVÁ Andrea

  Conference abstract

  Year: 2016, type: Conference abstract

2015

• Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry

  KOCÁKOVÁ Ilona MELICHAR Bohuslav KOCÁK Ivo BORTLÍČEK Zbyněk BÜCHLER Tomáš DUŠEK Ladislav PETRUŽELKA Luboš KOHOUTEK Milan PRAUSOVÁ Jana FÍNEK Jindřich MOHELNIKOVA-DUCHONOVA Beatrice VYZULA Rostislav

  Article in Periodical

  Anticancer Research, year: 2015, volume: 35, edition: 6